Editorial for “Diagnostic Performance of the 2018 EASL vs. LI‐RADS for Hepatocellular Carcinoma Using CT and MRI : A Systematic Review and Meta‐Analysis of Comparative Studies”
Journal of Magnetic Resonance Imaging · 2023
DOI: 10.1002/jmri.28714 ↗Kurz gefasst
Editorial in der Zeitschrift Journal of Magnetic Resonance Imaging, 2023. Verfasst von Victoria Chernyak. Beteiligte Einrichtung: Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Victoria Chernyak
Zitieren
APA
Chernyak, V. (2023). Editorial for “Diagnostic Performance of the 2018 EASL vs. LI‐RADS for Hepatocellular Carcinoma Using CT and MRI : A Systematic Review and Meta‐Analysis of Comparative Studies”. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.28714
Vancouver
Chernyak V. Editorial for “Diagnostic Performance of the 2018 EASL vs. LI‐RADS for Hepatocellular Carcinoma Using CT and MRI : A Systematic Review and Meta‐Analysis of Comparative Studies”. Journal of Magnetic Resonance Imaging. 2023. doi:10.1002/jmri.28714
BibTeX
@article{Chernyak2023,
author = {Chernyak, Victoria},
title = {Editorial for “Diagnostic Performance of the 2018 EASL vs. LI‐RADS for Hepatocellular Carcinoma Using CT and MRI : A Systematic Review and Meta‐Analysis of Comparative Studies”},
journal = {Journal of Magnetic Resonance Imaging},
year = {2023},
doi = {10.1002/jmri.28714}
}
EUVIMED